SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-202384
Filing Date
2021-06-29
Accepted
2021-06-28 20:54:53
Documents
1
Group Members
ATP III GP, LTD.SETH L. HARRISON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d126894dsc13da.htm SC 13D/A 61918
  Complete submission text file 0001193125-21-202384.txt   63638
Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169 212-468-5800
ATP Life Science Ventures, L.P. (Filed by) CIK: 0001593440 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Subject) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91051 | Film No.: 211055278
SIC: 2834 Pharmaceutical Preparations